AN UNBIASED VIEW OF PENTOBARBITAL SODIUM ADVERSE EFFECTS

Contraindicated (1)pentobarbital will decrease the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers may lead to reduced serum concentrations and lack of antimalarial efficacypentobarbital will decrease the level or effect of mavacamten by impacti